Development, Genetics, Genotype and Reagent - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Development

Genetics

Genotype

Reagent

Roche signs definitive share purchase agreement with long-term partner TIB.

The Pharma Data

SEPTEMBER 8, 2021

TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic. For example, in 2001 with anthrax and 2003 with SARS-CoV1, TIB Molbiol demonstrated their ability to develop PCR assays for the detection of new pathogens within days.

Genotype

Genotype Reagent Genetics Research

Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

The Pharma Data

MARCH 16, 2022

It’s critical to quickly and accurately identify variants to inform ongoing research – including the ongoing development of therapeutics and vaccines. To support customers performing human genotyping, TIB Molbiol provides custom-made LightSNiP assays for SNP analysis. 2, as well as other mutations, present in the novel B.1.1.529

In-Vitro

In-Vitro Genotype Reagent Protein

Roche signs definitive share purchase agreement with long-term partner TIB.

Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

Stay Connected